Strategic investment arm of Huahai Pharmaceuticals 华海药业(SHA:600521)Focused on early stage investment in innovative drugs/ therapeutics discovery and development in China or overseasWelcome to connect and share your ideas.

PlusOME focuses in the field of multi-omicsProviding consultation services, insights and customized reports on technological innovation in sequencing and other omics, its clinical transformation and applicationManaging "Builder_HL" wechat official account (微信公众号: 我是建设者)

Congenica is a digital health company enabling genomic medicine with the world’s leading clinical decision support platform for the interpretation of complex genomic data. Committed to integrating clinical genomics into healthcare by working on applications covering rare disease, oncology, prenatal health, wellness/disease predisposition/pharmacogenetics, and clinical studies.

The role undertaken to help secure new and increased investment from China to the UK, match and bring more UK business into Chinese market, focused on Life Science sector, including biopharma, medtech, diagnostics, new therapies, lab instruments, specialised clinical services.

Start-up company focused on liquid biopsy for cancer early diagnosis, prognosis and recurrence monitoring by developing exosomal RNA biomarkers.

Thoroughbred industrial training programme fully sponsored by HH Sheikh Mohammed, Vice President and Prime Minister of the United Arab Emirates and Ruler of Dubai.